Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis

Colorectal Disease

Volumn 14, Issue 8, 2012, Pages 947-952

  Bulow S ^a   Christensen, I J ^b   Hojen H ^a   Bjork J ^c   Elmberg, M ^c   Jarvinen H ^d   Lepisto A ^d   Nieuwenhuis, M ^e   Vasen, H ^e  

^a HVIDOVRE HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e Foundation for the Detection of Hereditary Tumours   (Netherlands)

Author keywords

Duodenal adenomatosis; Duodenal cancer; Familial adenomatous polyposis

Indexed keywords

APC PROTEIN;

ADENOMATOSIS; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DUODENAL ADENOMATOSIS; DUODENUM CANCER; ESOPHAGOGASTRODUODENOSCOPY; FAMILIAL ADENOMATOUS POLYPOSIS; FAMILIAL POLYPOSIS; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; DENMARK; DUODENAL NEOPLASMS; DUODENOSCOPY; FEMALE; FINLAND; FOLLOW-UP STUDIES; GASTROSCOPY; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; NORWAY; POPULATION SURVEILLANCE; PROGNOSIS; RISK; SWEDEN;

EID: 84864369424     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02844.x     Document Type: Article

References (25)

1. Bülow S. Results of national registration of familial adenomatous polyposis. Gut 2003; 52: 742-6.
2. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-42.
3. Galle TS, Juel K, Bülow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999; 34: 808-12.
4. Brosens LAA, Keller JJ, Offerhaus GJA, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005; 54: 1034-43.
5. Bülow S, Alm T, Fausa O et al. Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. Int J Colorectal Dis 1995; 10: 43-6.
6. Groves CJ, Saunders BP, Spigelman AD, Phillips RKS. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10year prospective study. Gut 2002; 50: 636-41.
7. Bülow S, Björk J, Christensen IJ et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004; 53: 381-6.
8. Lepistö A, Kiviluoto T, Halttunen J, Järvinen HJ. Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 2009; 41: 504-9.
9. Church JM, McGannon E, Hull-Boiner S et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35: 1170-3.
10. Gallagher MC, Phillips RK, Bulow S. Surveillance and management of upper gastrointestinal disease in familial adenomatous polyposis. Fam Cancer 2006; 5: 263-73.
11. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2: 783-5.
12. Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007; 61: 153-61.
13. Björk J, Åkerbrant H, Iselius L et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001; 121: 1127-35.
14. Nugent KP, Spigelman AD, Williams CB, Talbot IC, Phillips RKS. Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. J R Soc Med 1994; 87: 704-6.
15. Groves C, Lamlum H, Crabtree M et al. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polypsis. Am J Pathol 2002; 160: 2055-61.
16. Saurin JC, Ligneau B, Ponchon T et al. The influence of mutation site and age on the severity of duodenal polyposis in familial adenomatous polyposis. Gastrointest Endosc 2002; 55: 342-7.
17. Matsumoto T, Iida M, Kobori Y et al. Genetic predisposition to clinical manifestations in familial adenomatous polyposis with special reference to duodenal lesions. Am J Gastroenterol 2002; 97: 180-5.
18. Gallagher MC, Shankar A, Groves CJ, Russell RCG, Phillips RKS. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 2004; 91: 1157-64.
19. Müller MW, Dahmen R, Köninger J et al. Is there an advantage in performing a pancreas-preserving total duodenectomy in duodenal adenomatosis? Am J Surg 2008; 195: 741-8.
20. de Castro SM, van Eijck CH, Rutten JP et al. Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum. Br J Surg 2008; 95: 1380-6.
21. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618-9.
22. Phillips RK, Wallace MH, Lynch PM et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002; 50: 857-60.
23. Huang K, Gutierrez LP, Bülow S et al. Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study. Fam Cancer 2011; 10: 303-8.
24. Parc Y, Mabrut J-Y, Shields C, Mallorca Group. Surgical treatment of the duodenal manifestations of familial adenomatous polyposis. Br J Surg 2011; 98: 480-4.
25. Latchford AR, Neale KF, Spigelman AD, Phillips RKS, Clark SK. Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2009; 7: 659-63.